Contact

Richard G. Parker

Gibson Dunn (Washington)

Partner

Richard Parker is a partner in the Washington, D.C. office of Gibson, Dunn & Crutcher and a member of the Firm’s Antitrust and Competition Practice Group. Mr. Parker is a leading antitrust lawyer who has successfully represented clients before both enforcement agencies and the courts. As a trial lawyer and an antitrust regulatory lawyer, Mr. Parker has been involved in many major antitrust representations, including merger clearance cases, cartel matters, class actions, and government civil investigations. He has extensive experience representing clients in matters before the Federal Trade Commission (FTC) and the U.S. Department of Justice Antitrust Division. His experience in high-profile merger matters have earned him high honors, including being recognized by Chambers USA as a leading Lawyer in Antitrust, by Global Competition Review as “Litigator of the Week” and as a finalist for “Lawyer of the Year”, by the Legal Times, Best Lawyers in America, Lawdragon, and by Super Lawyers Magazine as one of the “Top 100 Washington, DC Lawyers”. Mr. Parker also was included on Benchmark Litigation’s “Top 100 Trial Lawyers in America” list. Mr. Parker joins the firm from O’Melveny & Myers where he served as co-chair of the Antitrust and Competition Practice. From 1998 to 2001, he served as the Senior Deputy Director and then as Director of the Bureau of Competition at the FTC.

Distinctions

Nominee, 2020 Antitrust Writing Awards: Business, Mergers

Nominee, 2016 Antitrust Writing Awards: Business, Intellectual Property

Nominee, 2015 Antitrust Writing Awards: Business, General Antitrust

Contact

Linked authors

Peter Alexiadis

King’s College (London)

Belgium 13 contributions 9179 visits

Nicholas Banasevic

Gibson Dunn (Brussels)

Belgium 11 contributions 24768 visits

Rachel S. Brass

Gibson Dunn (San Francisco)

United States 1 contribution 33 visits

Joel M. Cohen

Gibson Dunn (New York)

United States 1 contribution 242 visits

Marwan Elaraby

Gibson Dunn (Dubai)

United Arab Emirates 1 contribution 44 visits

1271 | Events

19 Sep 2016 Washington, DC 120 Merger Regimes: Multinational Deals in a World of Non-Convergence: US, EU, Brazil, China... See documents

9 Sep 2014 Washington A single merger control standard for the US and abroad? See documents

Articles

3826 Bulletin

Chris Wilson, Richard G. Parker, Adam J. Di Vincenzo The US DoJ for the first time elects binding arbitration to resolve a merger challenge (Novelis / Aleris Corporation)

4 September 2019 2990

This article has been nominated for the 2020 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On September 4, 2019, the U.S. Department of Justice’s Antitrust Division filed a complaint in the Northern District of Ohio challenging Novelis Inc.’s proposed (...)

Anna Fabish, Kenneth R. O’Rourke, Richard G. Parker, Ted Hassi The US FTC reaches a settlement with a pharmaceutical company in a reverse payment case (Cephalon)

28 May 2015 220

This article has been nominated for the 2016 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. The Federal Trade Commission (“FTC”) has reached a settlement resolving its claims that Cephalon, Inc. violated the antitrust laws by entering into reverse payment (...)

Katrina Robson, Maryanne S. Kane, Mimi Vu, Randall W. Edwards, Richard G. Parker The US District Court for the District of New Jersey rules that the Federal Trade Commission can pursue claims against a company for failure to have adequate data security (Wyndham Worldwide)

7 April 2014 184

This article has been nominated for the 2015 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Issue In a decision that is likely to result in increased federal enforcement actions against companies that suffer data security breaches but are found not to (...)

Jonathan Sallet, Kenneth R. O’Rourke, Richard G. Parker, Stephen McIntyre The US Supreme Court holds that reverse-payment in patent settlements should be reviewed under the antitrust rule of reason (Actavis)

17 June 2013 432

But Decision Raises as Many Questions as it Answers The Supreme Court yesterday held that it may be unlawful under the antitrust laws for a brand-name drug manufacturer to resolve patent litigation against an allegedly infringing generic drug maker by paying the generic to forestall market (...)

553 Review

Gary Zanfagna, Richard G. Parker Gary Zanfagna (Honeywell): Antitrust compliance from the inside

September 2017 553

In this interview, Gary Zanfagna talks about his experience as Chief Antitrust Counsel and Associate General Counsel of Honeywell International, and notably about the antitrust issues of a global acting company. Interview conducted by Richard G. Parker, O’Melveny & Myers, Washington. (...)